Development and Validation of Case-Finding Algorithms for Digestive Cancer in the Spanish Healthcare Database BIFAP

Author:

Fernández-Antón Encarnación12,Rodríguez-Miguel Antonio2ORCID,Gil Miguel3,Castellano-López Amelia4,de Abajo Francisco J.12ORCID

Affiliation:

1. Clinical Pharmacology Unit, University Hospital “Príncipe de Asturias”, 28805 Madrid, Spain

2. Department of Biomedical Sciences (Pharmacology), University of Alcalá (IRYCIS), 28805 Madrid, Spain

3. BIFAP (Base de datos para la Investigación Farmacoepidemiológica en el Ámbito Público), Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), 28022 Madrid, Spain

4. Department of Gastroenterology, University Hospital “Príncipe de Asturias”, 28805 Madrid, Spain

Abstract

Background: electronic health records (EHRs) are helpful tools in epidemiology despite not being primarily collected for research. In Spain, primary care physicians play a central role and manage patients even in specialized care. All of this introduces variability that may lead to diagnostic inconsistencies. Therefore, data validation studies are crucial, so we aimed to develop and validate case-finding algorithms for digestive cancer in the primary care database BIFAP. Methods: from 2001 to 2019, subjects aged 40–89 without a cancer history were included. Case-finding algorithms using diagnostic codes and text-mining were built. We randomly sampled, clustered, and manually reviewed 816 EHRs. Then, positive predictive values (PPVs) and 95% confidence intervals (95% CIs) for each cancer were computed. Age and sex standardized incidence rates (SIRs) were compared with those reported by the National Cancer Registry (REDECAN). Results: we identified 95,672 potential cases. After validation, the PPV (95% CI) for hepato-biliary cancer was 87.6% (81.8–93.4), for esophageal cancer, it was 96.2% (93.1–99.2), for pancreatic cancer, it was 89.4% (84.5–94.3), for gastric cancer, it was 92.5% (88.3–96.6), and for colorectal cancer, it was 95.2% (92.1–98.4). The SIRs were comparable to those reported by the REDECAN. Conclusions: the case-finding algorithms demonstrated high performance, supporting BIFAP as a suitable source of information to conduct epidemiologic studies of digestive cancer.

Funder

Institute of Health “Carlos III”

Publisher

MDPI AG

Subject

General Medicine

Reference20 articles.

1. López-Abente, G., Núñez, O., Pérez-Gómez, B., Aragonés, N., and Pollán, M. (2023, September 04). La Situación del Cáncer en España: Informe 2015. Instituto de Salud Carlos III: Madrid, Spain, 2015. Available online: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesCronicas/Documents/informes/cancer2015.pdf.

2. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J. Clin. Epidemiol.,2005

3. Epidemiologic research using probabilistic outcome definitions;Cai;Pharmacoepidemiol. Drug Saf.,2015

4. Identifying health outcomes in healthcare databases;Lanes;Pharmacoepidemiol. Drug Saf.,2015

5. Possible Sources of Bias in Primary Care Electronic Health Record Data Use and Reuse;Verheij;J. Med. Internet Res.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3